<DOC>
	<DOCNO>NCT00675740</DOCNO>
	<brief_summary>The aim study prospectively assess relative benefit either treatment rosiglitazone physical exercise endothelial function patient impair fast glucose impair glucose tolerance coronary artery disease ( CAD ) .</brief_summary>
	<brief_title>Physical Exercise Versus Rosiglitazone CAD Prediabetes</brief_title>
	<detailed_description />
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>impaired fast glucose impair glucose tolerance angiographic evidence coronary artery disease diabetes mellitus type I II preexist antidiabetic medication unstable angina indication coronary bypass surgery significant leave main disease myocardial infarction within precede 3 month ejection fraction &lt; 40 % significant heart valve disease severe metabolic disorder severe disorder lipoprotein metabolism thyroid disorder alcohol drug abuse pregnancy participation another trial</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>